We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Residential Cognitive and Interpersonal Therapy for Social Phobia

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00326430
First Posted: May 16, 2006
Last Update Posted: May 16, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Modum Bad
  Purpose
The purpose of this study is twofold: (1) to compare the effectiveness of two promising treatments for social phobia, a new cognitive therapy model (Clark & Wells, 1995; Borge et al., 2001) and interpersonal therapy (Lipsitz, Markowitz, & Cherry, 1997), adapted for inpatient groups; and (2) to study the empirical change processes in these therapies and compare them with the cognitive and interpersonal models of change.

Condition Intervention Phase
Social Phobia Behavioral: Cognitive Therapy, Interpersonal Therapy Phase 2 Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Primary Purpose: Treatment
Official Title: Residential Cognitive Therapy Versus Residential Interpersonal Therapy for Social Phobia: A Randomized Controlled Trial

Resource links provided by NLM:


Further study details as provided by Modum Bad:

Primary Outcome Measures:
  • Social Avoidance
  • Social Anxiety

Secondary Outcome Measures:
  • General Anxiety
  • Depression
  • Interpersonal Problems
  • Personality Disorders

Estimated Enrollment: 80
Study Start Date: October 2001
Estimated Study Completion Date: June 2004
Detailed Description:

Social phobia typically leads to severe impairment in work and other social life, and - without treatment - it can persist for decades. Given its prevalence, severity, and chronicity, effective treatment methods are strongly needed. However, traditional psychological and pharmacological treatments have had statistically significant, but clinically limited effects (Taylor, 1996).

Based on an empirical analysis of the cognitive processes in social phobia, Clark and Wells (1995) have developed a new cognitive model. Cognitive therapy (CT) derived from this model has been found to be superior to a combination of fluoxetine and self-exposure (Clark et al., 2003).

Social phobic symptoms may be viewed as a result of more general interpersonal difficulties and interpersonal psychotherapy (IPT) can be a reasonable alternative for social phobia (Lipsitz & Markowitz, 1996). A clinical case series indicates that social phobic patients improve during interpersonal psychotherapy for social phobia (IPT-SP; Lipsitz et al., 1999.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • DSM-IV criteria for social phobia
  • the patient consider social phobia as the main current problem
  • willingness to suspend use of psychotropic medication, alcohol and other substances
  • acceptance of random allocation
  • ability to speak Norwegian
  • age 18-65 years.

Exclusion Criteria:

  • a history of recurrent major depression currently treated sucessfully with antidepressant medications
  • has immediate need for additional treatment
  • current psychotic disorder or substance abuse
  • organic mental disorder
  • previously treated with similar models
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00326430


Locations
Norway
Modum Bad
Vikersund, Buskerud, Norway, N-3370
Sponsors and Collaborators
Modum Bad
Investigators
Study Chair: Asle Hoffart, Dr Psychol Modum Bad
Principal Investigator: Finn-Magnus Borge, Cand Psychol Modum Bad
  More Information

ClinicalTrials.gov Identifier: NCT00326430     History of Changes
Other Study ID Numbers: 1
First Submitted: May 15, 2006
First Posted: May 16, 2006
Last Update Posted: May 16, 2006
Last Verified: May 2006

Keywords provided by Modum Bad:
Social Phobia
Cognitive Therapy
Interpersonal Therapy
Efficacy
Process-Outcome

Additional relevant MeSH terms:
Phobic Disorders
Phobia, Social
Anxiety Disorders
Mental Disorders